Whole Exome Sequencing Uncovers the Genetic Complexity of Bicuspid Aortic Valve in Families with Early Onset Complications

Sara Mansoorshahi,Anji T Yetman,Malenka M Bissell,Yuli Y Kim,Hector Michelena,Dawn S Hui,Anthony Caffarelli,Maria G Andreassi,Ilenia Foffa,Dongchuan Guo,Rodolfo Citro,Margot De Marco,Justin T Tretter,Shaine A Morris,Simon C Body,Jessica X Chong,Michael J Bamshad,University of Washington Center for Rare Disease Research,BAVCon Investigators,EBAV Investigators,Dianna M Milewicz,Siddharth K Prakash

DOI: https://doi.org/10.1101/2024.02.07.24302406

2024-02-08

Abstract:Bicuspid Aortic Valve (BAV) is the most common adult congenital heart lesion with an estimated population prevalence of 1%. We hypothesize that early onset complications of BAV (EBAV) are driven by specific impactful genetic variants. We analyzed whole exome sequences (WES) to identify rare coding variants that contribute to BAV disease in 215 EBAV families. Predicted pathogenic variants of causal genes were present in 111 EBAV families (51% of total), including genes that cause BAV (8%) or heritable thoracic aortic disease (HTAD, 17%). After appropriate filtration, we also identified 93 variants in 26 novel genes that are associated with autosomal dominant congenital heart phenotypes, including recurrent deleterious variation of , , channelopathy genes, and type 1 and 5 collagen genes. These findings confirm our hypothesis that unique rare genetic variants contribute to early onset complications of BAV disease.

Genetic and Genomic Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Identifying the genetic variants that lead to early - onset complications of bicuspid aortic valve (BAV)**.

Specifically, the researchers hypothesized that early - onset BAV complications (EBAV) are driven by specific, high - impact genetic variants. To test this hypothesis, they analyzed whole - exome sequencing (WES) data from 215 EBAV families to determine whether rare coding variants contribute to BAV disease.

### Main problems and objectives:
1. **Identify the genetic variants that cause EBAV**: Through WES analysis, find the rare coding variants associated with EBAV.
2. **Confirm whether these variants are concentrated in known BAV or heritable thoracic aortic disease (HTAD) genes**: The researchers specifically focused on genes known to be associated with BAV or HTAD, such as GATA4, NOTCH1, SMAD6, and ROBO4, etc.
3. **Discover new candidate genes**: In addition to the known genes, the researchers also hope to find new candidate genes associated with EBAV.
4. **Compare the genetic differences between EBAV and other patients with early - onset thoracic aortic aneurysm or acute aortic dissection (ESTAD)**: By comparing gene variants in different cohorts, further verify the genetic uniqueness of EBAV.

### Research background:
- BAV is one of the most common congenital heart diseases in adults, with an estimated population prevalence of 0.5% - 2%.
- Approximately 10% of BAV patients require aortic valve surgery within the first two decades of life.
- EBAV is defined as a condition with clinical manifestations before the age of 30 due to aortic stenosis, aortic regurgitation, large thoracic aortic aneurysm, or aortic dissection.
- Previous studies have shown that EBAV patients may carry more pathogenic genetic variants, which may be the cause of their early - onset.

### Research methods:
- **Sample selection**: Include individuals who presented with BAV complications before the age of 30, and exclude patients with known genetic syndromes or complex congenital heart diseases.
- **Data analysis**: Use WES data and perform variant filtering through a customized seqr tool to screen out rare variants that may cause the disease.
- **Gene prioritization**: Based on the predicted pathogenicity and functional annotation of the variants, prioritize genes that appear in at least three unrelated EBAV patients.

### Results and conclusions:
- Predicted pathogenic variants were found in 111 EBAV families (51% of the total), including 8% of BAV genes and 17% of HTAD genes.
- Ninety - three variants in 26 new genes were discovered, and these genes are associated with autosomal - dominant congenital heart phenotypes.
- These findings support the researchers' hypothesis that unique rare genetic variants do contribute to the occurrence of EBAV.

In general, this study aims to reveal the genetic mechanisms underlying early - onset complications of bicuspid aortic valve through whole - exome sequencing, providing a scientific basis for further diagnosis and treatment.